Evidence map›Paper›PMID 35241467›Full record

ArticleBMJ open2022

Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma.

Jake R Thompson, Andrea L Smith, Serigne N Lo, Nadine A Kasparian, Robyn Pm Saw, Mbathio Dieng, Linda Seaman, Linda K Martin, Pascale Guitera, Donna Milne and 3 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Effectiveness of a stepped-care model to address fear of cancer recurrence in patients with early-stage melanoma: results at 6- and 12-month follow-up.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Supportive care needs in Australian melanoma patients and caregivers: results from a quantitative cross-sectional survey.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jake R ThompsonMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia jake.thompson@melanoma.org.au.ORCID 0000-0002-0823-3218
Andrea L SmithAustralian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0002-9194-4888
Serigne N LoMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.
Nadine A KasparianCincinnati Children's Center for Heart Disease and Mental Health, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0001-8075-6817
Robyn Pm SawMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.
Mbathio DiengNHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia.
Linda SeamanConsumer Representative, Sydney, New South Wales, Australia.
Linda K MartinMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.
Pascale GuiteraMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.
Donna MilneMelanoma and Skin Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Helen SchmidThe Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Anne E CustMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.
Iris BartulaMelanoma Institute Australia, University of Sydney, North Sydney, New South Wales, Australia.ORCID 0000-0002-4084-4115

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFear of cancer recurrence (FCR) is commonly reported by patients diagnosed with early-stage (0-II) melanoma and can have a significant impact on daily functioning. This study will pilot the implementation of the Melanoma Care Program, an evidence-based, psychological intervention to reduce FCR, into routine practice, using a stepped-care model. METHODS AND ANALYSIS: Intervention effectiveness and level of implementation will be investigated using a hybrid type I design. Between 4 weeks before and 1 week after their next dermatological appointment, patients with melanoma will be invited to complete the Fear of Cancer Recurrence Inventory Short-Form, measuring self-reported FCR severity. Using a stepped-care model, clinical cut-off points will guide the level of support offered to patients. This includes: (1) usual care, (2) ETHICS AND DISSEMINATION: Ethics approval was granted by the Sydney Local Health District-Royal Prince Alfred Zone (2020/ETH02518), protocol number: X20-0495. Results will be disseminated through peer-reviewed journals, conference presentations, social media and result summaries distributed to interested participants. TRIAL REGISTRATION DETAILS: (ACTRN12621000145808).

Indexed as

MelanomaSkin NeoplasmsCutaneous Malignant MelanomaFearHumansQuality of Lifeadult oncologyanxiety disordersdermatological tumoursmental healthqualitative research

Identifiers

PMID35241467
PMCPMC8896053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.